Efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase-producing Pseudomonas aeruginosa in a 1,000-bed tertiary hospital in Thailand
1
Issued Date
2026-05-01
Resource Type
eISSN
25396056
Scopus ID
2-s2.0-105036819297
Journal Title
Journal of Associated Medical Sciences
Volume
59
Issue
2
Start Page
421
End Page
427
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Associated Medical Sciences Vol.59 No.2 (2026) , 421-427
Suggested Citation
Khampakul J., Jumroon N., Chaihongsa N., Santanirand P. Efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase-producing Pseudomonas aeruginosa in a 1,000-bed tertiary hospital in Thailand. Journal of Associated Medical Sciences Vol.59 No.2 (2026) , 421-427. 427. doi:10.66285/JAMS.2026.071 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116496
Title
Efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase-producing Pseudomonas aeruginosa in a 1,000-bed tertiary hospital in Thailand
Author(s)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a prominent healthcare-associated pathogen with worldwide implications for public health. Distinguishing between carbapenemase-producing and noncarbapenemase-producing strains over an extended hospitalization period is vital in assessing the risk of treatment failure in infected patients. Objectives: To study the prevalence of carbapenemase genes and to evaluate the efficacy of the modified carbapenem inactivation method (mCIM) for detecting carbapenemase production among CRPA isolated from Thailand. Materials and methods: A total of 164 CRPA isolates were phenotypically tested for carbapenemase production by the mCIM comparing with genotypic detection of carbapenemase genes using the direct flow chip kits and conventional PCR. In addition, carbapenemase genes were identified by sequencing. Results: The carbapenemase genes, including bla<inf>IMP</inf>, bla<inf>VIM</inf>, bla<inf>NDM</inf>, bla<inf>GES</inf>, and bla<inf>SIM,</inf> were found in 83 (50.61%) isolates. The bla<inf>IMP</inf> showed to be the most prevalent gene, followed by bla<inf>VIM</inf> and bla<inf>NDM</inf>, respectively. Of these isolates, 68/83 (82%) of carbapenemase gene-positive isolates were positive by the mCIM assay. The 15 mCIM-negative isolates, six (40%) carried bla<inf>VIM-2</inf> gene, while five (33%) isolates contained bla<inf>GES-5</inf> . Moreover, bla<inf>IMP</inf> was detected in 3 isolates (20%) and one isolate (7%) of a combination between bla<inf>VIM</inf> and bla<inf>IMP</inf> genes. Furthermore, we noted that isolates carrying bla<inf>VIM-2</inf> were the most common among the mCIM-negative carbapenemase-producing P. aeruginosa (CPPA), followed by bla<inf>GES-5.</inf> Conclusion: This study represents a critical report on using mCIM to detect CPPA. It highlights that relying solely on mCIM may not be sufficient for the comprehensive detection of CPPA. Further approaches are needed to enhance the accuracy of detection in this context.